Good price  online

products details

Created with Pixso. Home Created with Pixso. Products Created with Pixso.
Chest Lung Cancer Drugs
Created with Pixso. Afatinib Maleate Tablets 30mg 30 Tablets Box Second Generation EGFR TKI Irreversible Pan HER Inhibitor for NSCLC

Afatinib Maleate Tablets 30mg 30 Tablets Box Second Generation EGFR TKI Irreversible Pan HER Inhibitor for NSCLC

Brand Name: Sichuan Kelun Pharmaceutical Co., Ltd.
Model Number: Afatinib KL-20213349
MOQ: Negotiable
Price: Please contact a specialist WhatsApp:55342706
Delivery Time: Negotiable
Payment Terms: Western Union,MoneyGram,T/T
Detail Information
Place of Origin:
Chengdu, Sichuan, China
Certification:
NMPA/GMP
Packaging Details:
Negotiable
Supply Ability:
Negotiable
Highlight:

Second Generation EGFR TKI

,

Irreversible Pan HER Blocker

,

EGFR Exon 19 Deletion NSCLC

Product Description

Afatinib Maleate 30mg x 30 Tablets

[Product Name]

Generic Name: Afatinib Maleate

Brand Name: Kejixin

Specification: 30mg x 30 Tablets

[Active Ingredient]

Afatinib Maleate

[Indications]

1. First-line EGFR mutation-positive advanced NSCLC. 2. Squamous NSCLC after platinum chemotherapy. 3. NSCLC with uncommon EGFR mutations (G719X, L861Q, S768I).

[Mechanism of Action]

Second-gen irreversible ErbB family blocker covalently binding EGFR/HER2/ErbB4. Superior to first-gen reversible TKIs with broader inhibition and OS benefit.

[Dosage and Administration]

Starting dose: 40mg. 30mg for dose reduction. Take on empty stomach 1h before or 3h after meal. Dose escalate to 50mg if tolerated.

[Adverse Reactions]

Diarrhea (95%), rash (89%), stomatitis (71%), paronychia (56%). ILD, hepatotoxicity, keratitis, LV dysfunction.

[Storage]

Store below 30C. Keep out of reach of children.

[Shelf Life]

24 months

Approval: H20213349